W.F. Mourad

Mount Sinai Beth Israel

Papers

1

Total Citations

9

H-Index

1

About

W.F. Mourad is a leading surgical oncologist whose research focuses on the interplay between advanced surgical techniques and adjuvant therapies in head and neck cancer. Dr. Mourad’s work is particularly concerned with optimizing treatment outcomes for patients with squamous cell carcinoma, a common and aggressive malignancy of the upper aerodigestive tract. A major contribution is the investigation of transoral robotic surgery (TORS), a minimally invasive approach that has revolutionized tumor resection. Dr. Mourad’s pivotal 2013 study, which has garnered 9 citations, critically examined the risk of retropharyngeal node recurrence following TORS. This work highlighted a crucial clinical insight: the absence of adjuvant radiotherapy after robotic surgery may significantly increase the risk of cancer returning in these deep-seated lymph nodes. By identifying this potential gap in treatment, Dr. Mourad has provided essential guidance for multidisciplinary care, urging clinicians to consider postoperative radiation to improve long-term disease control. This research underscores a commitment to refining cancer management protocols, ensuring that surgical innovation is paired with appropriate complementary therapies to maximize patient survival.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Lack of Adjuvant Radiotherapy May Increase Risk of Retropharyngeal Node Recurrence in Patients with Squamous Cell Carcinoma of the Head and Neck after Transoral Robotic Surgery
9 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Mount Sinai Beth Israel

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago